GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Afrocentric Investment Corp Ltd (JSE:ACT) » Definitions » EPS without NRI

Afrocentric Investment (JSE:ACT) EPS without NRI : R-1.81 (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Afrocentric Investment EPS without NRI?

Afrocentric Investment's earnings per share without non-recurring items for the six months ended in Dec. 2023 was R20.91. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was R-1.81.

During the past 12 months, Afrocentric Investment's average earnings per share (NRI) Growth Rate was -107.80% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -14.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -3.30% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was -16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Afrocentric Investment's EPS without NRI or its related term are showing as below:

JSE:ACT' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -76.9   Med: 11   Max: 400.8
Current: -14

During the past 13 years, Afrocentric Investment's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 400.80% per year. The lowest was -76.90% per year. And the median was 11.00% per year.

JSE:ACT's 3-Year EPS without NRI Growth Rate is ranked worse than
77.37% of 495 companies
in the Healthcare Providers & Services industry
Industry Median: 10.4 vs JSE:ACT: -14.00

Afrocentric Investment's EPS (Diluted) for the six months ended in Dec. 2023 was R0.21. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was R0.29.

Afrocentric Investment's EPS (Basic) for the six months ended in Dec. 2023 was R0.21. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was R0.30.


Afrocentric Investment EPS without NRI Historical Data

The historical data trend for Afrocentric Investment's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Afrocentric Investment EPS without NRI Chart

Afrocentric Investment Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.55 0.60 0.53 0.35

Afrocentric Investment Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.27 23.07 -22.72 20.91

Competitive Comparison of Afrocentric Investment's EPS without NRI

For the Medical Care Facilities subindustry, Afrocentric Investment's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Afrocentric Investment's PE Ratio without NRI Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Afrocentric Investment's PE Ratio without NRI falls into.



Afrocentric Investment EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was R-1.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Afrocentric Investment  (JSE:ACT) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Afrocentric Investment EPS without NRI Related Terms

Thank you for viewing the detailed overview of Afrocentric Investment's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Afrocentric Investment (JSE:ACT) Business Description

Traded in Other Exchanges
N/A
Address
37 Conrad Road, Florida North, Roodepoort, ZAF, 1709
Afrocentric Investment Corp Ltd is a black-owned investment holding company with an investment portfolio focused on services to the healthcare sector. It seeks to invest in healthcare-related businesses that demonstrate prospects for growth as well as diversify its revenue sources while contributing to the sustainable health and welfare of South African communities. The company provides health administration and health risk management solutions to the healthcare industry. It also provides a range of complementary services to its traditional medical scheme clients and a portfolio of healthcare-related enterprises. These services include information technology solutions, transactional switching, specialized disease management, pharmaceutical wholesaling, amongst others.

Afrocentric Investment (JSE:ACT) Headlines

From GuruFocus

Enact To Participate at the Bank of America 2023 Financial Services Conference

By Stock market mentor Stock market mentor 02-03-2023

Enact Announces Neenu Kainth as Chief Customer Experience Officer

By GlobeNewswire GlobeNewswire 08-22-2022

Enact Receives Ratings Upgrade from Moody's

By sperokesalga sperokesalga 03-01-2023

Enact Reports Second Quarter 2023 Results

By Marketwired 08-01-2023

Enact to Host Fourth Quarter 2022 Earnings Call February 7th

By Stock market mentor Stock market mentor 01-06-2023